Alevacure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally.

Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, Cardiology, Blood-related, respiratory, CNS & HBV-HCV among others. Alevacure has launched 6 biosimilars in the Domestic Market & RoW markets & they are the domestic leader in three biologics. Alevacure subsidiary - leading the creation of India’s first Septiheal Natural wound healer, Troil- Muscular and Joint Pain Reliever Emulsion.

With 20+ brands, One R&D centers and 1 manufacturing facilities established across the country, we have ensured a strong foothold not just in India but also globally with a wide network across India. Our state-of-the-art API facilities ensures that our supply chain is vertically integrated providing flexibility over control of manufacturing. We have cemented strategic global partnerships that are a result of alliances with local and multi-national companies which are at the helm of leadership in key therapeutic areas. The key objective of our widespread presence across markets is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.